Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Filipits

Showing results (71-80 of 122) with videos related to

Pageof 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2019
Prediction of Distant Recurrence Using EndoPredict Among Women with ER<sup>+</sup>, HER2<sup>-</sup> Node-Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy OnlyMartin Filipits, Peter Dubsky, Margaretha Rudas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapyMargaretha Rudas, Martina Lehnert, Anh Huynh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2011
Adjuvant sequencing of tamoxifen and anastrozole is superior to tamoxifen alone in postmenopausal women with low proliferating breast cancerZsuzsanna Bago-Horvath, Margaretha Rudas, Peter Dubsky, et al.
Annals of Surgery|July 4, 2012
Pretreatment serum C-reactive protein levels predict benefit from multimodality treatment including radical surgery in malignant pleural mesothelioma: a retrospective multicenter analysisBahil Ghanim, Mir Alireza Hoda, Max-Paul Winter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic ProgramMartin Filipits, Robert Pirker, Ariane Dunant, et al.
Ecotoxicology and Environmental Safety|March 29, 2026
Comparative analysis of four PFAS regarding their toxicity to zebrafish developmentBenjamin Natha, Raimund Widhalm, Sebastian Granitzer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 6, 2018
Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR-Mutated NSCLCAnna Buder, Maximilian J Hochmair, Sophia Schwab, et al.
Cancers|June 25, 2020
Hot Spot TERT Promoter Mutations Are Rare in Sporadic Pancreatic Neuroendocrine Neoplasms and Associated with Telomere Length and Epigenetic Expression PatternsAlexandra Posch, Sarah Hofer-Zeni, Eckhard Klieser, et al.
Journal of Hematology & Oncology|April 18, 2015
EVI1 promotes tumor growth via transcriptional repression of MS4A3Gerwin Heller, Anna Rommer, Katarina Steinleitner, et al.
Pharmacoeconomics|November 19, 2014
Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patientsPatricia R Blank, Martin Filipits, Peter Dubsky, et al.
Pageof 13

Showing results (71-80 of 122) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2019
Prediction of Distant Recurrence Using EndoPredict Among Women with ER<sup>+</sup>, HER2<sup>-</sup> Node-Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy OnlyMartin Filipits, Peter Dubsky, Margaretha Rudas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapyMargaretha Rudas, Martina Lehnert, Anh Huynh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2011
Adjuvant sequencing of tamoxifen and anastrozole is superior to tamoxifen alone in postmenopausal women with low proliferating breast cancerZsuzsanna Bago-Horvath, Margaretha Rudas, Peter Dubsky, et al.
Annals of Surgery|July 4, 2012
Pretreatment serum C-reactive protein levels predict benefit from multimodality treatment including radical surgery in malignant pleural mesothelioma: a retrospective multicenter analysisBahil Ghanim, Mir Alireza Hoda, Max-Paul Winter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic ProgramMartin Filipits, Robert Pirker, Ariane Dunant, et al.
Ecotoxicology and Environmental Safety|March 29, 2026
Comparative analysis of four PFAS regarding their toxicity to zebrafish developmentBenjamin Natha, Raimund Widhalm, Sebastian Granitzer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 6, 2018
Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR-Mutated NSCLCAnna Buder, Maximilian J Hochmair, Sophia Schwab, et al.
Cancers|June 25, 2020
Hot Spot TERT Promoter Mutations Are Rare in Sporadic Pancreatic Neuroendocrine Neoplasms and Associated with Telomere Length and Epigenetic Expression PatternsAlexandra Posch, Sarah Hofer-Zeni, Eckhard Klieser, et al.
Journal of Hematology & Oncology|April 18, 2015
EVI1 promotes tumor growth via transcriptional repression of MS4A3Gerwin Heller, Anna Rommer, Katarina Steinleitner, et al.
Pharmacoeconomics|November 19, 2014
Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patientsPatricia R Blank, Martin Filipits, Peter Dubsky, et al.
Pageof 13